Florie Borel

Florie Borel serves as the Senior Director and Head of Delivery & Preclinical Development at Arbor Biotechnologies since January 2022. Prior to this role, Florie held multiple positions at Apic Bio, Inc., including Director and Associate Director of Preclinical Research & Development in Gene Therapy, leading to the FDA clearance of an IND application for the program APB-102. Florie's experience encompasses significant contributions at Shire as Senior Scientist and Associate Director, advancing gene therapy research, and at UMass Medical School, where translational efforts supported a clinical program for SOD1-linked ALS. Early career work includes positions as a Junior Researcher at uniQure and a PhD student at Amsterdam Molecular Therapeutics, culminating in a publication on multidrug resistance transporters. Florie holds an Executive Certificate in Management and Leadership from MIT Sloan and multiple degrees in Biological and Biomedical Sciences from distinguished institutions.